Shutterstock How excited would you be about a medication that lowered your risk of cardiovascular death, heart attack, or stroke by 1.5%? Excited enough to spend a few thousand dollars a year on the drug? I expect not. What if, instead, the drug reduced those same terrible outcomes by 20%? That’s probably enough benefit to…
Generic meds are supposed to be relatively cheap; multiple companies can make the same molecule, leading to price-lowering competition. But that’s not always what happens in the US market. Look at the prices of these generics, in the US vs Canada: We need to take regulatory or legislative steps to reduce the price of generic…
Imagine that you are gasping for breath, literally on the verge of death. Then someone injects you with a medicine and – miracle! – you are perfectly healthy again. Would you pay $300 for that injection? The treatment is epinephrine; your illness was a life-threatening allergy. And that $300 price? That reflects a six-fold increase…
Here is a fascinating picture from the Wall Street Journal, showing how much Medicare has been spending on hepatitis C treatments lately. You can see that the cost is rising dramatically: Keep in mind, however, that the new and expensive hepatitis C treatments currently on the market will dramatically reduce costs in the future, because…
American manufacturing has declined precipitously in the past few decades. Companies that were once the source of fabulous wealth for Americans – the U.S. Steel profits that enriched the Carnegie family, the Ford Motor F -1.29% Company profits that enriched its eponymous family – are now struggling to keep up with foreign competitors. Thank God…
I must not be the only person to wonder how pharmaceutical companies succeed with direct to consumer advertisements when, stuck in the middle of all their TV ads, are those long lists of side effects. You know what I mean. After watching a smiling and attractive person running through a field after receiving some wonder…
People have criticized The Affordable Care Act for amounting to a large transfer of wealth, from wealthy Americans to those not as well off. But the real transfer of wealth has been from United States to other developed nations, whose healthcare costs we have subsidized for many years by paying so generously for many of…
Last fall, an article in the New England Journal presented a powerful picture of just how much effort different pharmaceutical companies make to give poor people access to their products. Here is the picture from that article: The captains of industry are a competitive group of people, I am told. They like to see where…
A while back, DVD companies hoping to sell their products in countries like Poland faced a dilemma. They could sell their products at a nice profit in the booming U.S. market, but to sell products in those other countries, they had to lower their prices. Such variable pricing is a common business practice. All kinds of services…
For years now, the pharmaceutical industry has justified its prices and its profits by reminding us that their products eventually go off patent, and are then offered cheaply to people around the world in generic form. They warned us that the pipeline for new and innovative drugs is less and less promising, because so many…